Selected research
Industry Research
Spermicides Industry Research Report 2026
Market perspective
The global Spermicides market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Spermicides is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Spermicides is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Spermicides is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Spermicides include Advantage-S, Conceptrol, Crinone, Delfen Foam, Emko, Encare, Endometrin, First-Progesterone VGS and Gynol II, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Spermicides market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Spermicides Market by Company
Advantage-S
Conceptrol
Crinone
Delfen Foam
Emko
Encare
Endometrin
First-Progesterone VGS
Gynol II
Phexxi
Prochieve
Spermicides Segment by Type
Suppositories
Creams
Foams
Gels
Film
Spermicides Segment by Application
Online Pharmacies
Retail Pharmacies
Hospital
Spermicides Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Spermicides market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Spermicides and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Spermicides.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Spermicides manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Spermicides by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Spermicides in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Suppositories
- Creams
- Foams
- Gels
- Film
Applications
- Online Pharmacies
- Retail Pharmacies
- Hospital
Companies covered
- Advantage-S
- Conceptrol
- Crinone
- Delfen Foam
- Emko
- Encare
- Endometrin
- First-Progesterone VGS
- Gynol II
- Phexxi
- Prochieve
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Spermicides Market Size (2021-2032)
- 2.2.2 Global Spermicides Sales (2021-2032)
- 2.2.3 Global Spermicides Market Average Price (2021-2032)
- 2.3 Spermicides by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Suppositories
- 2.3.3 Creams
- 2.3.4 Foams
- 2.3.5 Gels
- 2.3.6 Film
- 2.4 Spermicides by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Online Pharmacies
- 2.4.3 Retail Pharmacies
- 2.4.4 Hospital
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Spermicides Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Spermicides Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Spermicides Revenue of Manufacturers (2021-2026)
- 3.4 Global Spermicides Average Price by Manufacturers (2021-2026)
- 3.5 Global Spermicides Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Spermicides, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Spermicides, Product Type & Application
- 3.8 Global Manufacturers of Spermicides, Established Date
- 3.9 Global Spermicides Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Advantage-S
- 4.1.1 Advantage-S Company Information
- 4.1.2 Advantage-S Business Overview
- 4.1.3 Advantage-S Spermicides Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Advantage-S Spermicides Product Portfolio
- 4.1.5 Advantage-S Recent Developments
- 4.2 Conceptrol
- 4.2.1 Conceptrol Company Information
- 4.2.2 Conceptrol Business Overview
- 4.2.3 Conceptrol Spermicides Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Conceptrol Spermicides Product Portfolio
- 4.2.5 Conceptrol Recent Developments
- 4.3 Crinone
- 4.3.1 Crinone Company Information
- 4.3.2 Crinone Business Overview
- 4.3.3 Crinone Spermicides Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Crinone Spermicides Product Portfolio
- 4.3.5 Crinone Recent Developments
- 4.4 Delfen Foam
- 4.4.1 Delfen Foam Company Information
- 4.4.2 Delfen Foam Business Overview
- 4.4.3 Delfen Foam Spermicides Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Delfen Foam Spermicides Product Portfolio
- 4.4.5 Delfen Foam Recent Developments
- 4.5 Emko
- 4.5.1 Emko Company Information
- 4.5.2 Emko Business Overview
- 4.5.3 Emko Spermicides Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Emko Spermicides Product Portfolio
- 4.5.5 Emko Recent Developments
- 4.6 Encare
- 4.6.1 Encare Company Information
- 4.6.2 Encare Business Overview
- 4.6.3 Encare Spermicides Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Encare Spermicides Product Portfolio
- 4.6.5 Encare Recent Developments
- 4.7 Endometrin
- 4.7.1 Endometrin Company Information
- 4.7.2 Endometrin Business Overview
- 4.7.3 Endometrin Spermicides Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Endometrin Spermicides Product Portfolio
- 4.7.5 Endometrin Recent Developments
- 4.8 First-Progesterone VGS
- 4.8.1 First-Progesterone VGS Company Information
- 4.8.2 First-Progesterone VGS Business Overview
- 4.8.3 First-Progesterone VGS Spermicides Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 First-Progesterone VGS Spermicides Product Portfolio
- 4.8.5 First-Progesterone VGS Recent Developments
- 4.9 Gynol II
- 4.9.1 Gynol II Company Information
- 4.9.2 Gynol II Business Overview
- 4.9.3 Gynol II Spermicides Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Gynol II Spermicides Product Portfolio
- 4.9.5 Gynol II Recent Developments
- 4.10 Phexxi
- 4.10.1 Phexxi Company Information
- 4.10.2 Phexxi Business Overview
- 4.10.3 Phexxi Spermicides Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Phexxi Spermicides Product Portfolio
- 4.10.5 Phexxi Recent Developments
- 4.11 Prochieve
- 4.11.1 Prochieve Company Information
- 4.11.2 Prochieve Business Overview
- 4.11.3 Prochieve Spermicides Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Prochieve Spermicides Product Portfolio
- 4.11.5 Prochieve Recent Developments
5 Global Spermicides Market Scenario by Region
- 5.1 Global Spermicides Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Spermicides Sales by Region: 2021-2032
- 5.2.1 Global Spermicides Sales by Region: 2021-2026
- 5.2.2 Global Spermicides Sales by Region: 2027-2032
- 5.3 Global Spermicides Revenue by Region: 2021-2032
- 5.3.1 Global Spermicides Revenue by Region: 2021-2026
- 5.3.2 Global Spermicides Revenue by Region: 2027-2032
- 5.4 North America Spermicides Market Facts & Figures by Country
- 5.4.1 North America Spermicides Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Spermicides Sales by Country (2021-2032)
- 5.4.3 North America Spermicides Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Spermicides Market Facts & Figures by Country
- 5.5.1 Europe Spermicides Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Spermicides Sales by Country (2021-2032)
- 5.5.3 Europe Spermicides Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Spermicides Market Facts & Figures by Country
- 5.6.1 Asia Pacific Spermicides Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Spermicides Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Spermicides Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Spermicides Market Facts & Figures by Country
- 5.7.1 South America Spermicides Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Spermicides Sales by Country (2021-2032)
- 5.7.3 South America Spermicides Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Spermicides Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Spermicides Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Spermicides Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Spermicides Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Spermicides Sales by Type (2021-2032)
- 6.1.1 Global Spermicides Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Spermicides Sales Market Share by Type (2021-2032)
- 6.2 Global Spermicides Revenue by Type (2021-2032)
- 6.2.1 Global Spermicides Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Spermicides Revenue Market Share by Type (2021-2032)
- 6.3 Global Spermicides Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Spermicides Sales by Application (2021-2032)
- 7.1.1 Global Spermicides Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Spermicides Sales Market Share by Application (2021-2032)
- 7.2 Global Spermicides Revenue by Application (2021-2032)
- 7.2.1 Global Spermicides Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Spermicides Revenue Market Share by Application (2021-2032)
- 7.3 Global Spermicides Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Spermicides Value Chain Analysis
- 8.1.1 Spermicides Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Spermicides Production Mode & Process
- 8.2 Spermicides Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Spermicides Distributors
- 8.2.3 Spermicides Customers
9 Global Spermicides Analyzing Market Dynamics
- 9.1 Spermicides Industry Trends
- 9.2 Spermicides Industry Drivers
- 9.3 Spermicides Industry Opportunities and Challenges
- 9.4 Spermicides Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst